Aprea Therapeutics

APRENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.280 M

$0.74 -3.01%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$12.6M

Loss-making

Shares outstanding

12,591,136

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#435ImmuronIMRN$10.0M
#436Alzamend NeuroALZN$9.36M
#437Aprea TherapeuticsAPRE$9.28M
#438BullFrog AIBFRG$9.14M
#439FibroBiologicsFBLG$9.06M

What if Aprea Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,404,394

Per share 3,262,407× higher

Bitcoin $1.72T

$136,588.45

Per share 185,330× higher

Nvidia $5.48T

$435,215.55

Per share 590,523× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Aprea Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.